STOCKHOLM--(BUSINESS WIRE)--Regulatory News: Medivir AB (STO:MVIRB), a research-based specialty pharmaceutical company focused on infectious diseases, today announces that a new Nomination Committee has been appointed consisting of; Maria Wikström, Länsförsäkringar Fondförvaltning AB, Bo Öberg, representing A shareholders, Frank Larsson, Handelsbanken Kapitalförvaltning and Göran Pettersson, Chairman of the Board.
